Early intervention for the ocular and neurodevelopmental sequelae of Fetal Valproate Syndrome

Zia I Carrim1, Lorna McKay, Sikander S Sidiki

  • 1Department of Ophthalmology and Orthoptics, Southern General Hospital, and Royal Hospital for Sick Children, Glasgow, UK. zia.carrim@doctors.org.uk

Insights

Antiepileptic drugs can cause birth defects. This study highlights Fetal Valproate Syndrome in siblings, emphasizing the need for early detection of craniofacial, ocular, and neurodevelopmental issues.

Area of Science:

  • Teratology
  • Developmental Biology
  • Clinical Genetics

Background:

  • Antiepileptic drugs (AEDs) are known teratogens, posing risks to women of childbearing age.
  • While neural tube defects are recognized, other congenital malformations associated with AEDs require further investigation.
  • Fetal Valproate Syndrome (FVS) is a specific example of AED teratogenicity.

Observation:

  • Two siblings presented with features consistent with Fetal Valproate Syndrome.
  • These individuals exhibited characteristic craniofacial abnormalities.
  • Associated ocular and neurodevelopmental problems were also noted.

Findings:

  • The siblings displayed a distinct pattern of craniofacial malformations indicative of Fetal Valproate Syndrome.
  • Ocular anomalies were identified in conjunction with the craniofacial features.
  • Neurodevelopmental deficits were present, suggesting a broader impact of prenatal valproate exposure.

Implications:

  • Early recognition of Fetal Valproate Syndrome is crucial for affected infants.
  • Timely intervention for ocular and neurodevelopmental problems can improve patient outcomes.
  • This case series underscores the importance of comprehensive assessment and management in children exposed to antiepileptic drugs in utero.